Shiyong Fan

Peking University Shenzhen Hospital — China

Medicine · Health Sciences

15h-index938citations61works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(8), HER2/EGFR in Cancer Research(7), Monoclonal and Polyclonal Antibodies Research(7), SARS-CoV-2 detection and testing(5), Pharmacological Receptor Mechanisms and Effects(4)

Publications61 total

NQO1-responsive Trimethyl lock benzoquinone: A cleavable linker strategy for antibody-drug conjugates
Journal of Controlled Release·2025
VPS34 inhibition as a host-targeting anti-coronaviral strategy: Rational design of YBM with optimized pharmacokinetic parameters
Acta Pharmaceutica Sinica B·2025Open Access
Hylanemos: An integrated solution for materials simulations based on Kohn-Sham DFT
Science China Technological Sciences·2025· 2 cited
A Blood-Labyrinth Barrier-Crossing Nanoprobe for Sensitive Magnetic Resonance Imaging of the Inner Ear
Chemical & Biomedical Imaging·2025· 2 citedOpen Access
Genome-wide KAS-Seq mapping of leukocytes in ischemia-reperfusion model reveals IL7R as a potential therapeutic target for ischemia-reperfusion injury
Scientific Reports·2025· 1 citedOpen Access
From Psychological Placebo to Consumption Resonance: A Study on the Construction Path and Practical Strategies of ‘Relaxation’ in Brand Marketing
2025Open Access
Chemical cross‐linking facilitates antigen uptake and presentation and provides improved protection from Mpox with a dual‐antigen subunit vaccine
MedComm·2025· 4 citedOpen Access
Genome-wide KAS-Seq mapping of leukocytes in ischemia-reperfusion model reveals IL7R as a potential therapeutic target for ischemia-reperfusion injury
2024Open Access
Novel antibody-antibiotic conjugate using KRM-1657 as payload eliminates intracellular MRSA in vitro and in vivo
Bioorganic Chemistry·2024· 4 cited
[Theoretical models for influenza vaccination behavior at the individual level].
PubMed·2024
AGCM-22, a novel cetuximab-based EGFR-targeting antibody-drug-conjugate with highly selective anti-glioblastoma efficacy
Bioorganic & Medicinal Chemistry·2024· 9 cited
Efficacy and safety of molnupiravir in patients with Omicron variant vaccine breakthrough COVID-19 infection: a randomized, controlled trial
Frontiers in Pharmacology·2023Open Access
A novel antibody-KSP inhibitor conjugate improves KSP inhibitor efficacy in vitro and in vivo
Biomaterials·2023· 6 cited
[Progress in research of influenza vaccination in pregnant women].
PubMed·2023
Temporal and Spatial Distribution of SARS-CoV-2 Aerosols in a Large-Scale Fangcang Shelter Hospital in Shanghai, China
Engineering·2023· 7 citedOpen Access
[Performance of screening of contacts of COVID-19 cases in same flight].
PubMed·2023
Antiviral effects and tissue exposure of tetrandrine against SARS‐CoV‐2 infection and COVID‐19
MedComm·2023· 10 citedOpen Access
Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination
Figshare·2023Open Access
Disease Progression of Hospitalized Elderly Patients with Omicron BA.2 Treated with Molnupiravir
Infectious Diseases and Therapy·2022· 8 citedOpen Access
Discovery and Optimization of Quinoline Analogues as Novel Potent Antivirals against Enterovirus D68
Journal of Medicinal Chemistry·2022· 9 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Wu Zhong(19), Xinbo Zhou(9), Dian Xiao(7), Lianqi Liu(7), Yanming Wang(7), Xinbo Zhou(7), Bo‐Hua Zhong(7), Ruiyuan Cao(7), Weiguo Shi(7), Xueyuan Jin(5), Song Li(4), Fei Xie(4), Long Chen(4), Chao Shang(4), Fei Xie(3), Song Li(3), Wěi Li(3), Kai Lv(3), Zhibing Zheng(3), Ping Zhang(3)